Table 1 Selected Baseline Characteristics.

From: Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI

 

CHUM (Selective TATT)

N = 69

CHUS (Ticagrelor-DAPT)

N = 108

Unadjustedp-value

Age (yrs)

64.6 ± 13.6

62.2 ± 10.9

0.183

Men

49 (71%)

79 (73%)

0.863

Diabetes

17 (25%)

10 (9%)

0.009*

Hypertension

37 (54%)

41 (38%)

0.045*

Dyslipidemia

31 (45%)

43 (40%)

0.534

BMI (kg/m2)

27.1 ± 5.2

27.0 ± 4.2

0.898

eGFR (mL/min)

84.5 ± 35.2

100.7 ± 38.5

0.007*

Hemoglobin (g/L)

142.3 ± 27.2

141.1 ± 16.3

0.706

Stroke/TIA History

2 (3%)

2 (2%)

0.641

CHADS2 Score

1 (0–2)

0 (0–1)

0.012*

CHA2DS2-VASC Score

1 (1–3)

1 (0–2)

0.160

HASBLED Score

1 (0–2)

1 (0–1)

0.074

Prior PCI

11 (16%)

1 (1%)

0.0002*

Radial Access

57 (83%)

81 (75%)

0.268

FMC-Device Time (min)

127 (101–178)

97 (79–121)

<0.001*

FMC-Device ≤ 90 min

15 (22%)

43 (40%)

0.021*

Drug-Eluting Stent Use

45 (65%)

84 (78%)

0.083

Procedural Success

64 (93%)

108 (100%)

0.008*

Cardiac Arrest

16 (23%)

11 (10%)

0.031*

LVEF

39% ± 9%

37% ± 9%

0.892

No. Dysf. Apical Segments

4 (3–4)

4 (4–4)

0.469

  1 Dysf. Segment

1 (1%)

6 (6%)

0.293†

  2 Dysf. Segments

9 (13%)

11 (10%)

 

  3 Dysf. Segments

10 (15%)

9 (8%)

 

  4 Dysf. Segments

49 (71%)

82 (76%)

 
  1. BMI: Body mass index. eGFR: Estimate glomerular filtration rate (Cockcroft-Gault method). TIA: Transient ischemic attack. PCI: Percutaneous coronary intervention. FMC: First medical contact. LVEF: Left ventricular ejection fraction.
  2. *p < 0.05. †Result for the Chi2 analysis of the number of affected apical segments.
Back to article page